Joaquin Murieta: Fact, Fiction and Folklore

This work explores the legendary 19th-century California bandit Joaquin Murieta as he is manifest in the history, literature and folklore of the West. The first section of the work examines in some detail the historical milieu which gave rise to widespread banditry during the California gold rush, at which time Murieta is said to have been active. The second section traces the development of the literary hero Joaquin Murieta from his creation by John Rollin Ridge through a number of American, Mexican, Chilean, Spanish and French incarnations. Section three similarly traces Murieta as a folk hero through a cycle of legends perpetuated by California\u27s Anglo-American folk community. Section four of the work returns to history, examining in some detail the evolving relationship between California\u27s Mexican-American and Anglo-American populations in the century following the gold rush. The fifth section explores Murieta\u27s development and perpetuation as a folk hero in the~ Mexican-American folk community. The work\u27s final section examines some dynamic mechanisms at work in the evolution of Murieta folk lore, and suggests some directions for further study

Long-term results of cyclosporine-steroid therapy in 131 non-matched cadaveric renal transplants.

One-hundred-and-twenty-eight recipients of 131 consecutive, non-matched cadaver renal allografts were treated with cyclosporine and steroids. They have been followed for 4 to 6 yr. Cumulative patient survival at 1-yr was 92.2% and at 6yr it is 77.8%. Cumulative graft survival at 1-yr was 79.4% and at 6 yr it is 50.0%. After the high-risk 1st yr, the rate of graft loss was even and similar to that reported after the 1st yr for grafts treated with azathioprine and steroids. This indicates that cyclosporine nephrotoxicity has not had an obvious adverse effect on the survival of chronically functioning grafts. The results were better with primary grafting versus retransplantation, but were not significantly influenced by age, diabetes mellitus, or a delayed switch in patients from cyclosporine to azathioprine. We have concluded that cyclosporine-steroid therapy is safe and effective for long-term use after cadaveric renal transplantation

On the Photometric Accuracy of RHESSI Imaging and Spectrosocopy

We compare the photometric accuracy of spectra and images in flares observed with the Ramaty High Energy Solar Spectroscopic Imager (RHESSI)}spacecraft. We test the accuracy of the photometry by comparing the photon fluxes obtained in different energy ranges from the spectral-fitting software SPEX with those fluxes contained in the images reconstructed with the Clean, MEM, MEM-Vis, Pixon, and Forward-fit algorithms. We quantify also the background fluxes, the fidelity of source geometries, and spatial spectra reconstructed with the five image reconstruction algorithms. We investigate the effects of grid selection, pixel size, field-of-view, and time intervals on the quality of image reconstruction. The detailed parameters and statistics are provided in an accompanying CD-ROM and web page. We find that Forward-fit, Pixon, and Clean have a robust convergence behavior and a photometric accuracy in the order of a few percents, while MEM does not converge optimally for large degrees of freedom (for large field-of-views and/or small pixel sizes), and MEM-Vis suffers in the case of time-variable sources. This comparative study documents the current status of the RHESSI spectral and imaging software, one year after launch.Comment: 2 Figures, full version on http://www.lmsal.com/~aschwand/eprints/2003_photo/index.htm

Cardiac interventions in patients with achondroplasia: a systematic review.

Patients with achondroplasia and other causes of dwarfism suffer from increased rates of cardiovascular disease relative to the remainder of the population. Few studies have examined these patients when undergoing cardiac surgery or percutaneous intervention. This systematic review examines the literature to determine outcomes following cardiac intervention in this unique population. An electronic search was performed in the English literature to identify all reports of achondroplasia, dwarfism, and cardiac intervention. Of the 5,274 articles identified, 14 articles with 14 cases met inclusion criteria. Patient-level data was extracted and analyzed. Median patient age was 55.5 [interquartile ranges (IQR), 43.8, 59.8] years, median height 102.0 [98.8, 112.5] cm, median BMI 32.1 [27.0, 45.9], and 57.1% (8/14) were male. Of these 14 patients, nine had the following documented skeletal abnormalities: 66.7% (6/9) had scoliosis, 66.7% (6/9) had kyphosis, 11.1% (1/9) had lordosis, 11.1% (1/9) pectus carinatum and 11.1% (1/9) spinal stenosis. Coronary artery disease was present in 53.8% (7/13), and 30.8% (4/13) patients previously suffered a myocardial infarction. Of the eight patients who underwent cardiac surgery, 37.5% (3/8) underwent multivessel coronary artery bypass grafting, 37.5% (3/8) underwent aortic valve replacement, 25.0% (2/8) underwent type A aortic dissection repair, and the remaining 12.5% (1/8) underwent pulmonary thromboendarterectomy. Six patients underwent percutaneous intervention. Median cardiopulmonary bypass time was 136.5 [110.0, 178.8] minutes. Median arterial cannula size was 20.0 [20.0, 24.0] Fr. Bicaval cannulation was performed in all cases describing cannulation strategy (5/5). Median superior vena cava cannula size was 28.0 [28.0, 28.0] Fr, and inferior vena cava cannula size was 28.0 [28.0, 28.0] Fr. No mortality was reported with a median follow up time of 6.0 [6.0, 10.5] months. In conclusion, Common cardiac procedures can be performed with reasonable safety in this patient population. Operative adjustments may need to be made with respect to equipment to accommodate patient-specific needs